Imre Noth

Carter, H., Costa, R. M., Adams, T. S., Gilchrist, T., Emch, C. E., Bame, M., . . . Gurczynski, S. J. (2024). Dendritic Cell - Fibroblast Crosstalk via TLR9 and AHR Signaling Drives Lung Fibrogenesis.. bioRxiv. doi:10.1101/2024.03.15.584457

Raghu, G., Ghazipura, M., Fleming, T. R., Aronson, K. I., Behr, J., Brown, K. K., . . . Martinez, F. J. (2024). Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives' Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 209(6), 647-669. doi:10.1164/rccm.202312-2213SO

Kim, J. S., Montesi, S. B., Adegunsoye, A., Humphries, S. M., Salisbury, M. L., Hariri, L. P., . . . Podolanczuk, A. J. (2023). Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. ANNALS OF THE AMERICAN THORACIC SOCIETY, 20(12), 1683-1693. doi:10.1513/AnnalsATS.202303-188PS

Kim, J. S., Murray, S., Yow, E., Anstrom, K. J., Kim, H. J., Flaherty, K. R., . . . Noth, I. (2024). Comparison of Pirfenidone and Nintedanib Post Hoc Analysis of the CleanUP-IPF Study. CHEST, 165(5), 1163-1173. doi:10.1016/j.chest.2023.11.035

Zhang, D., Adegunsoye, A., Oldham, J. M., Kozlitina, J., Garcia, N., Poonawalla, M., . . . Newton, C. A. (2023). Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. EUROPEAN RESPIRATORY JOURNAL, 62(5). doi:10.1183/13993003.00441-2023

Kim, J. S., Ma, S. -F., Ma, J. Z., Huang, Y., Bonham, C. A., Oldham, J. M., . . . Noth, I. (2024). Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis. CHEST, 165(3), 621-631. doi:10.1016/j.chest.2023.09.035

Davis, C. L., Bjoring, M., Hursh, J., Smith, S., Blevins, C., Blackstone, K., . . . Enfield, K. (2023). The Intensive Care Unit Bundle Board: A Novel Real-Time Data Visualization Tool to Improve Maintenance Care for Invasive Catheters. APPLIED CLINICAL INFORMATICS, 14(05), 892-902. doi:10.1055/a-2165-5861

Oldham, J. M., Allen, R. J., Lorenzo-Salazar, J. M., Flores, C., Wain, L. V., & Noth, I. (2023). PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis? Reply. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 207(12), 1644-1645. doi:10.1164/rccm.202303-0402LE

Oldham, J. M., Allen, R. J., Lorenzo-Salazar, J. M., Molyneaux, P. L., Ma, S. -F., Joseph, C., . . . Noth, I. (2023). PCSK6 and Survival in Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 207(11), 1515-1524. doi:10.1164/rccm.202205-0845OC

Ruan, P., Todd, J. L., Zhao, H., Liu, Y., Vinisko, R., Soellner, J. F., . . . Salisbury, M. L. (2023). Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. RESPIRATORY RESEARCH, 24(1). doi:10.1186/s12931-023-02435-0

Reynolds, C. J., Del Greco, F., Allen, R. J., Flores, C., Jenkins, R. G., Maher, T. M., . . . Minelli, C. (2023). The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study. EUROPEAN RESPIRATORY JOURNAL, 61(5). doi:10.1183/13993003.01585-2022

Peljto, A. L., Blumhagen, R. Z., Walts, A. D., Cardwell, J., Powers, J., Corte, T. J., . . . Schwartz, D. A. (2023). Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 207(9), 1194-1202. doi:10.1164/rccm.202207-1331OC

Adegunsoye, A., Newton, C. A., Oldham, J. M., Ley, B., Lee, C. T., Linderholm, A. L., . . . Noth, I. (2023). Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts. NATURE COMMUNICATIONS, 14(1). doi:10.1038/s41467-023-37193-6

Huang, Y., Guzy, R., Ma, S. -F., Bonham, C. A., Jou, J., Schulte, J. J., . . . Noth, I. (2023). Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis. BMJ OPEN RESPIRATORY RESEARCH, 10(1). doi:10.1136/bmjresp-2022-001391

Kim, J. S., Kim, J., Yin, X., Hiura, G. T., Anderson, M. R., Hoffman, E. A., . . . Oelsner, E. C. (2023). Associations of hiatus hernia with CT-based interstitial lung changes: the MESA Lung Study. EUROPEAN RESPIRATORY JOURNAL, 61(1). doi:10.1183/13993003.03173-2021

Podolanczuk, A., Kim, J. S., Cooper, C. B., Lasky, J. A., Murray, S., Oldham, J. M., . . . Martinez, F. (2022). Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial. BMC PULMONARY MEDICINE, 22(1). doi:10.1186/s12890-022-02281-8

Geng, Y., Li, L., Yan, J., Liu, K., Yang, A., Zhang, L., . . . Fan, X. (2022). Author Correction: PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis.. Nature communications, 13(1), 7749. doi:10.1038/s41467-022-35543-4

Zhang, D., Newton, C. A., Wang, B., Povysil, G., Noth, I., Martinez, F. J., . . . Garcia, C. K. (2022). Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis. EUROPEAN RESPIRATORY JOURNAL, 60(6). doi:10.1183/13993003.00577-2022

Geng, Y., Li, L., Yan, J., Liu, K., Yang, A., Zhang, L., . . . Fan, X. (2022). PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis. NATURE COMMUNICATIONS, 13(1). doi:10.1038/s41467-022-34870-w

Bonham, C. A., & Noth, I. (2022). Idiopathic Pulmonary Fibrosis Genetic Risk Factors, Function, and Mechanisms? The Concepts Are Starting to Gel. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206(10), 1197-1199. doi:10.1164/rccm.202208-1591ED

Fainberg, H. P., Oldham, J. M., Molyneaux, P. L., Allen, R. J., Kraven, L. M., Fahy, W. A., . . . Jenkins, R. G. (2022). Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort. LANCET DIGITAL HEALTH, 4(12), E862-E872. doi:10.1016/S2589-7500(22)00173-X

Partanen, J. J., Happola, P., Zhou, W., Lehisto, A. A., Ainola, M., Sutinen, E., . . . Koskela, J. T. (2022). Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics. CELL GENOMICS, 2(10). doi:10.1016/j.xgen.2022.100181

Zhang, D., Povysil, G., Newton, C. A., Maher, T. M., Molyneaux, P. L., Noth, I., . . . Garcia, C. K. (2022). Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206(7), 903-905. doi:10.1164/rccm.202203-0622LE

Allen, R. J., Oldham, J. M., Jenkins, D. A., Leavy, O. C., Guillen-Guio, B., Melbourne, C. A., . . . Wain, L. V. (2023). Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study. LANCET RESPIRATORY MEDICINE, 11(1), 65-73. doi:10.1016/S2213-2600(22)00251-X

Kim, J. S., Manichaikul, A. W., Hoffman, E. A., Balte, P., Anderson, M. R., Bernstein, E. J., . . . Podolanczuk, A. J. (2023). MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study. THORAX, 78(6), 566-573. doi:10.1136/thorax-2021-218139

Lipinski, J. H., Erb-Downward, J. R., Huffnagle, G. B., Flaherty, K. R., Martinez, F. J., Moore, B. B., . . . O'Dwyer, D. N. (2022). Toll-Interacting Protein and Altered Lung Microbiota in Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206(2), 224-227. doi:10.1164/rccm.202111-2590LE

Zhang, D., Povysil, G., Kobeissy, P. H., Li, Q., Wang, B., Amelotte, M., . . . Garcia, C. K. (2022). Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206(1), 56-69. doi:10.1164/rccm.202110-2439OC

Allen, R. J., Stockwell, A., Oldham, J. M., Guillen-Guio, B., Schwartz, D. A., Maher, T. M., . . . Wain, L. V. (2022). Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis. THORAX, 77(8), 829-833. doi:10.1136/thoraxjnl-2021-218577

Kraven, L. M., Taylor, A. R., Molyneaux, P. L., Maher, T., McDonough, J., Mura, M., . . . Wain, L. V. (2022). Cluster analysis of transcriptomic datasets to identify endotypes of idiopathic pulmonary fibrosis. THORAX. doi:10.1136/thoraxjnl-2021-218563

Todd, J. L., Neely, M. L., Overton, R., Mulder, H., Roman, J., Lasky, J. A., . . . Palmer, S. M. (2022). Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort (Jan, 10.1007/s00408-021-00505-y, 2022). LUNG, 200(1), 19. doi:10.1007/s00408-022-00516-3

Todd, J. L., Neely, M. L., Overton, R., Mulder, H., Roman, J., Lasky, J. A., . . . Palmer, S. M. (2022). Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort. LUNG, 200(1), 11-18. doi:10.1007/s00408-021-00505-y

Kim, J. S., Anderson, M. R., Bernstein, E. J., Oelsner, E. C., Raghu, G., Noth, I., . . . Podolanczuk, A. J. (2021). Associations of D-Dimer with Computed Tomographic Lung Abnormalities, Serum Biomarkers of Lung Injury, and Forced Vital Capacity MESA Lung Study. ANNALS OF THE AMERICAN THORACIC SOCIETY, 18(11), 1839-1848. doi:10.1513/AnnalsATS.202012-1557OC

Biblowitz, K., Lee, C., Zhu, D., Noth, I., Vij, R., Strek, M. E., . . . Adegunsoye, A. (2021). Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease. ERJ OPEN RESEARCH, 7(4). doi:10.1183/23120541.00254-2021

Martinez, F. J., Anstrom, K. J., & Noth, I. (2021). Antimicrobial Therapy and Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis Reply. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 326(11), 1071-1072. doi:10.1001/jama.2021.11813

Huang, Y., Oldham, J. M., Ma, S. -F., Unterman, A., Liao, S. -Y., Barros, A. J., . . . Noth, I. (2021). Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 204(2), 197-208. doi:10.1164/rccm.202008-3093OC

Noth, I., Cottin, V., Chaudhuri, N., Corte, T. J., Johannson, K. A., Wijsenbeek, M., . . . Maher, T. M. (2021). Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. EUROPEAN RESPIRATORY JOURNAL, 58(1). doi:10.1183/13993003.01518-2020

Guardela, B. M. J., Sun, J., Zhang, T., Xu, B., Balnis, J., Huang, Y., . . . Herazo-Maya, J. D. (2021). 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study. EBIOMEDICINE, 69. doi:10.1016/j.ebiom.2021.103439

Hohmann, M. S., Habiel, D. M., Espindola, M. S., Huang, G., Jones, I., Narayanan, R., . . . Hogaboam, C. M. (2021). Antibody-mediated depletion of CCR10⁺EphA3⁺ cells ameliorates fibrosis in IPF. JCI INSIGHT, 6(11). doi:10.1172/jci.insight.141061

Martinez, F. J., Yow, E., Flaherty, K. R., Snyder, L. D., Durheim, M. T., Wisniewski, S. R., . . . Noth, I. (2021). Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 325(18), 1841-1851. doi:10.1001/jama.2021.4956

Budzikowski, J. D., Foy, J. J., Rashid, A. A., Chung, J. H., Noth, I., & Armato, S. G. I. I. I. (2021). Radiomics-based assessment of idiopathic pulmonary fibrosis is associated with genetic mutations and patient survival. JOURNAL OF MEDICAL IMAGING, 8(3). doi:10.1117/1.JMI.8.3.031903

Leavy, O. C., Ma, S. -F., Molyneaux, P. L., Maher, T. M., Oldham, J. M., Flores, C., . . . Allen, R. J. (2021). Proportion of Idiopathic Pulmonary Fibrosis Risk Explained by Known Common Genetic Loci in European Populations. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 203(6), 775-778. doi:10.1164/rccm.202008-3211LE

Adegunsoye, A., Morisset, J., Newton, C. A., Oldham, J. M., Vittinghoff, E., Linderholm, A. L., . . . Ley, B. (2021). Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis. EUROPEAN RESPIRATORY JOURNAL, 57(3). doi:10.1183/13993003.02872-2020

Espindola, M. S., Habiel, D. M., Coelho, A. L., Stripp, B., Parks, W. C., Oldham, J., . . . Hogaboam, C. M. (2021). Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 203(4), 458-470. doi:10.1164/rccm.201910-1977OC

Podolanczuk, A. J., Noth, I., & Raghu, G. (2021). Idiopathic pulmonary fibrosis: prime time for a precision-based approach to treatment with N-acetylcysteine. EUROPEAN RESPIRATORY JOURNAL, 57(1). doi:10.1183/13993003.03551-2020

Wang, B. R., Edwards, R., Freiheit, E. A., Ma, Y., Burg, C., de Andrade, J., . . . Flaherty, K. R. (2020). The Pulmonary Fibrosis Foundation Patient Registry Rationale, Design, and Methods. ANNALS OF THE AMERICAN THORACIC SOCIETY, 17(12), 1620-1628. doi:10.1513/AnnalsATS.202001-035SD

Crews, M. S., Bartholmai, B. J., Adegunsoye, A., Oldham, J. M., Montner, S. M., Karwoski, R. A., . . . Chung, J. H. (2020). Automated CT Analysis of Major Forms of Interstitial Lung Disease. JOURNAL OF CLINICAL MEDICINE, 9(11). doi:10.3390/jcm9113776

Noth, I., & Otoupalova, E. (2020). The Bloom Is in Bud for Interstitial Lung Diseases. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 202(10), 1338-1339. doi:10.1164/rccm.202007-2855ED

Kim, J. S., Steffen, B. T., Podolanczuk, A. J., Kawut, S. M., Noth, I., Raghu, G., . . . Lederer, D. J. (2021). Associations of ω-3 Fatty Acids With Interstitial Lung Disease and Lung Imaging Abnormalities Among Adults. AMERICAN JOURNAL OF EPIDEMIOLOGY, 190(1), 95-108. doi:10.1093/aje/kwaa168

Casanova, N. G., Zhou, T., Gonzalez-Garay, M. L., Lussier, Y. A., Sweiss, N., Ma, S. -F., . . . Garcia, J. G. N. (2021). MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survival. TRANSLATIONAL RESEARCH, 228, 1-12. doi:10.1016/j.trsl.2020.07.009

Graham, J., Ventura, I. B., Newton, C. A., Lee, C., Boctor, N., Pugashetti, J. V., . . . Oldham, J. M. (2020). Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype. EUROPEAN RESPIRATORY JOURNAL, 56(6). doi:10.1183/13993003.01205-2020

Snyder, L. D., Mosher, C., Holtze, C. H., Lancaster, L. H., Flaherty, K. R., Noth, I., . . . Whelan, T. P. M. (2020). Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry. BMJ OPEN RESPIRATORY RESEARCH, 7(1). doi:10.1136/bmjresp-2020-000567

Adegunsoye, A., Neborak, J. M., Zhu, D., Cantrill, B., Garcia, N., Oldham, J. M., . . . Mokhlesi, B. (2020). CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. CHEST, 158(4), 1701-1712. doi:10.1016/j.chest.2020.04.067

Adegunsoye, A., Alqalyoobi, S., Linderholm, A., Bowman, W. S., Lee, C. T., Pugashetti, J. V., . . . Oldham, J. M. (2020). Circulating Plasma Biomarkers of Survival in Antifibrotic-Treated Patients With Idiopathic Pulmonary Fibrosis. CHEST, 158(4), 1526-1534. doi:10.1016/j.chest.2020.04.066

Todd, J. L., Vinisko, R., Liu, Y., Neely, M. L., Overton, R., Flaherty, K. R., . . . Belperio, J. A. (2020). Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort. BMC PULMONARY MEDICINE, 20(1). doi:10.1186/s12890-020-1103-4

Anstrom, K. J., Noth, I., Flaherty, K. R., Edwards, R. H., Albright, J., Baucom, A., . . . Martinez, F. J. (2020). Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial. RESPIRATORY RESEARCH, 21(1). doi:10.1186/s12931-020-1326-1

Guillen-Guio, B., Lorenzo-Salazar, J. M., Ma, S. -F., Hou, P. -C., Hernandez-Beeftink, T., Corrales, A., . . . Flores, C. (2020). Sepsis-associated acute respiratory distress syndrome in individuals of European ancestry: a genome-wide association study. LANCET RESPIRATORY MEDICINE, 8(3), 258-266. doi:10.1016/S2213-2600(19)30368-6

Alqalyoobi, S., Adegunsoye, A., Linderholm, A., Hrusch, C., Cutting, C., Ma, S. -F., . . . Oldham, J. M. (2020). Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 201(2), 250-253. doi:10.1164/rccm.201907-1343LE

Hobbs, B. D., Putman, R. K., Araki, T., Nishino, M., Gudmundsson, G., Gudnason, V., . . . Viviano, L. (2019). Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 200(11), 1402-1413. doi:10.1164/rccm.201903-0511OC

Ley, B., Torgerson, D. G., Oldham, J. M., Adegunsoye, A., Liu, S., Li, J., . . . Wolters, P. J. (2019). Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 200(9), 1154-1163. doi:10.1164/rccm.201902-0360OC

Todd, J. L., Neely, M. L., Overton, R., Durham, K., Gulati, M., Huang, H., . . . Whelan, T. P. (2019). Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry. RESPIRATORY RESEARCH, 20(1). doi:10.1186/s12931-019-1190-z

Casanova, N., Zhou, T., Gonzalez-Garay, M. L., Rosas, I. O., Goldberg, H. J., Ryter, S. W., . . . Garcia, J. G. N. (2019). Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes. SCIENTIFIC REPORTS, 9. doi:10.1038/s41598-019-50585-3

Noth, I., Wijsenbeek, M., Kolb, M., Bonella, F., Moros, L., Wachtlin, D., & Corte, T. J. (2019). Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials. EUROPEAN RESPIRATORY JOURNAL, 54(3). doi:10.1183/13993003.01797-2018

Newton, C. A., Zhang, D., Oldham, J. M., Kozlitina, J., Ma, S. -F., Martinez, F. J., . . . Garcia, C. K. (2019). Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 200(3), 336-347. doi:10.1164/rccm.201809-1646OC

Maher, T. M., Stowasser, S., Nishioka, Y., White, E. S., Cottin, V., Noth, I., . . . Jenkins, R. G. (2019). Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. LANCET RESPIRATORY MEDICINE, 7(9), 771-779. doi:10.1016/S2213-2600(19)30255-3

Moore, C., Blumhagent, R. Z., Yang, I. V., Walts, A., Powers, J., Walker, T., . . . Schwartz, D. A. (2019). Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 200(2), 199-208. doi:10.1164/rccm.201810-1891OC

Adegunsoye, A., Oldham, J. M., Bellam, S. K., Montner, S., Churpek, M. M., Noth, I., . . . Chung, J. H. (2019). Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. ANNALS OF THE AMERICAN THORACIC SOCIETY, 16(5), 580-588. doi:10.1513/AnnalsATS.201807-443OC

Adegunsoye, A., Oldham, J. M., Sperling, A. I., Noth, I., Strek, M. E., & Chung, J. H. (2019). Prognostic Impact of Mediastinal Lymph Nodes in Interstitial Lung Diseases: Is Environmental Exposure the Offender? Reply. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 199(8), 1041-1042. doi:10.1164/rccm.201811-2208LE

Lorenzo-Salazar, J. M., Ma, S. -F., Jou, J., Hou, P. -C., Guillen-Guio, B., Allen, R. J., . . . Flores, C. (2019). Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing. ERJ OPEN RESEARCH, 5(2). doi:10.1183/23120541.00071-2019

Newton, C. A., Oldham, J. M., Ley, B., Anand, V., Adegunsoye, A., Liu, G., . . . Garcia, C. K. (2019). Telomere length and genetic variant associations with interstitial lung disease progression and survival. EUROPEAN RESPIRATORY JOURNAL, 53(4). doi:10.1183/13993003.01641-2018

Adegunsoye, A., Oldham, J. M., Bonham, C., Hrusch, C., Nolan, P., Klejch, W., . . . Chung, J. H. (2019). Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment An Observational Cohort Study with Independent Validation. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 199(6), 747-759. doi:10.1164/rccm.201804-0761OC

Barros, A., Oldham, J., & Noth, I. (2019). Genetics of Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 357(5), 379-383. doi:10.1016/j.amjms.2019.02.009

Sturek, J., & Noth, I. (2019). Wandering out of the GWAS wilderness: a new pathway paradigm for complex disease genetics. THORAX, 74(3), 215-216. doi:10.1136/thoraxjnl-2018-212511

Adegunsoye, A., Vij, R., & Noth, I. (2019). Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. CHEST, 155(5), 1026-1040. doi:10.1016/j.chest.2018.12.011

Bonham, C. A., Hrusch, C. L., Blaine, K. M., Manns, S. T., Vij, R., Oldham, J. M., . . . Sperling, A. I. (2019). T cell Co-Stimulatory molecules ICOS and CD28 stratify idiopathic pulmonary fibrosis survival.. Respiratory medicine: X, 1, 100002. doi:10.1016/j.yrmex.2019.100002

Bermea, R. S., Adegunsoye, A., Oldham, J., Ventura, I., Lee, C., Chung, J. H., . . . Vij, R. (2019). Anti-RNA binding protein positivity in idiopathic interstitial pneumonia. RESPIRATORY MEDICINE, 146, 23-27. doi:10.1016/j.rmed.2018.11.015

Celada, L. J., Kropski, J. A., Herazo-Maya, J. D., Luo, W., Creecy, A., Abad, A. T., . . . Drake, W. P. (2018). PD-1 up-regulation on CD4⁺ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production. SCIENCE TRANSLATIONAL MEDICINE, 10(460). doi:10.1126/scitranslmed.aar8356

Raghu, G., Pellegrini, C. A., Yow, E., Flaherty, K. R., Meyer, K., Noth, I., . . . Collard, H. R. (2018). Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. LANCET RESPIRATORY MEDICINE, 6(9), 707-714. doi:10.1016/S2213-2600(18)30301-1

Noth, I., Oelberg, D., Kaul, M., Conoscenti, C. S., & Raghu, G. (2018). Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in the USA. EUROPEAN RESPIRATORY JOURNAL, 52(1). doi:10.1183/13993003.02106-2017

Adegunsoye, A., Oldham, J. M., Bellam, S. K., Chung, J. H., Chung, P. A., Biblowitz, K. M., . . . Strek, M. E. (2018). African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. EUROPEAN RESPIRATORY JOURNAL, 51(6). doi:10.1183/13993003.00255-2018

Oldham, J. M., Adegunsoye, A., Khera, S., Lafond, E., Noth, I., Strek, M. E., . . . Chung, J. H. (2018). Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. ANNALS OF THE AMERICAN THORACIC SOCIETY, 15(6), 764-766. doi:10.1513/AnnalsATS.201801-053RL

Chung, J. H., Oldham, J. M., Montner, S. M., Vij, R., Adegunsoye, A., Husain, A. N., . . . Strek, M. E. (2018). CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines. AMERICAN JOURNAL OF ROENTGENOLOGY, 210(5), 1034-1041. doi:10.2214/AJR.17.18947

Oldham, J. M., Witt, L. J., Adegunsoye, A., Chung, J. H., Lee, C., Hsu, S., . . . Noth, I. (2018). N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia. BMC PULMONARY MEDICINE, 18. doi:10.1186/s12890-018-0599-3

Jouneau, S., Noth, I., Wijsenbeek, M., Kolb, M., Bonella, F., Wachtlin, D., & Corte, T. J. (2018). Sécurité cardiovasculaire du nintédanib dans des sous-groupes selon le risque cardiovasculaire initial dans les essais TOMORROW et INPULSIS. Revue des Maladies Respiratoires, 35, A143-A144. doi:10.1016/j.rmr.2017.10.316

Maher, T. M., Stowasser, S., Nishioka, Y., White, E. S., Cottin, V., Noth, I., . . . Jenkins, R. G. (2018). Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial. BMJ OPEN RESPIRATORY RESEARCH, 5(1). doi:10.1136/bmjresp-2018-000325

Chung, J. H., Cox, C. W., Montner, S. M., Adegunsoye, A., Oldham, J. M., Husain, A. N., . . . Strek, M. E. (2018). CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF ROENTGENOLOGY, 210(2), 307-313. doi:10.2214/AJR.17.18384

Rosas, I. O., Goldberg, H. J., Collard, H. R., El-Chemaly, S., Flaherty, K., Hunninghake, G. M., . . . Choi, A. M. K. (2018). A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis. CHEST, 153(1), 94-104. doi:10.1016/j.chest.2017.09.052

Allen, R. J., Porte, J., Braybrooke, R., Flores, C., Fingerlin, T. E., Oldham, J. M., . . . Jenkins, R. G. (2017). Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. LANCET RESPIRATORY MEDICINE, 5(11), 869-880. doi:10.1016/S2213-2600(17)30387-9

Adegunsoye, A., Oldham, J. M., Chung, J. H., Montner, S. M., Lee, C., Witt, L. J., . . . Churpek, M. (2018). Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. CHEST, 153(2), 349-360. doi:10.1016/j.chest.2017.09.026

Herazo-Maya, J. D., Sun, J., Molyneaux, P. L., Li, Q., Villalba, J. A., Tzouvelekis, A., . . . Kaminski, N. (2017). Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. LANCET RESPIRATORY MEDICINE, 5(11), 857-868. doi:10.1016/S2213-2600(17)30349-1

Carlin, B. W., Schuldheisz, S. K., Noth, I., & Criner, G. J. (2017). Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care. POSTGRADUATE MEDICINE, 129(7), 725-733. doi:10.1080/00325481.2017.1353885

Huang, Y., Ma, S. -F., Espindola, M. S., Vij, R., Oldham, J. M., Huffnagle, G. B., . . . Noth, I. (2017). Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 196(2), 208-219. doi:10.1164/rccm.201607-1525OC

Chung, J. H., Montner, S. M., Adegunsoye, A., Oldham, J. M., Husain, A. N., Vij, R., . . . Strek, M. E. (2017). CT findings associated with survival in chronic hypersensitivity pneumonitis. EUROPEAN RADIOLOGY, 27(12), 5127-5135. doi:10.1007/s00330-017-4936-3

Adegunsoye, A., Oldham, J. M., Fernández Pérez, E. R., Hamblin, M., Patel, N., Tener, M., . . . Vij, R. (2017). Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis.. ERJ open research, 3(3), 16-2017. doi:10.1183/23120541.00016-2017

Hrusch, C. L., Manns, S. T., Bryazka, D., Casaos, J., Bonham, C. A., Jaffery, M. R., . . . Sperling, A. I. (2018). ICOS protects against mortality from acute lung injury through activation of IL-5⁺ ILC2s. MUCOSAL IMMUNOLOGY, 11(1), 61-70. doi:10.1038/mi.2017.42

Adegunsoye, A., Oldham, J. M., Valenzi, E., Lee, C., Witt, L. J., Chen, L., . . . Husain, A. N. (2017). Interstitial Pneumonia With Autoimmune Features Value of Histopathology. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 141(7), 960-969. doi:10.5858/arpa.2016-0427-OA

Haycock, P. C., Burgess, S., Nounu, A., Zheng, J., Okoli, G. N., Bowden, J., . . . Smith, G. D. (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases A Mendelian Randomization Study. JAMA ONCOLOGY, 3(5), 636-651. doi:10.1001/jamaoncol.2016.5945

O'Dwyer, D. N., Norman, K. C., Xia, M., Huang, Y., Gurczynski, S. J., Ashley, S. L., . . . Moore, B. B. (2017). The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes. SCIENTIFIC REPORTS, 7. doi:10.1038/srep46560

Chung, J. H., Montner, S. M., Adegunsoye, A., Lee, C., Oldham, J. M., Husain, A. N., . . . Strek, M. E. (2017). CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. AMERICAN JOURNAL OF ROENTGENOLOGY, 208(6), 1229-1236. doi:10.2214/AJR.16.17121

Raghu, G., Noth, I., & Martinez, F. (2017). N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open. LANCET RESPIRATORY MEDICINE, 5(1), E1-E2. doi:10.1016/S2213-2600(16)30327-7

Adegunsoye, A., Oldham, J. M., Husain, A. N., Chen, L., Hsu, S., Montner, S., . . . Strek, M. E. (2017). Autoimmune Hypothyroidism As a Predictor of Morality in Chronic Hypersensitivity Pneumonitis. FRONTIERS IN MEDICINE, 4. doi:10.3389/fmed.2017.00170

Singla, S., Zhou, T., Javaid, K., Abbasi, T., Casanova, N., Zhang, W., . . . Machado, R. F. (2016). Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis. PULMONARY CIRCULATION, 6(4), 465-471. doi:10.1086/688316

Oldham, J. M., Lee, C., Valenzi, E., Witt, L. J., Adegunsoye, A., Hsu, S., . . . Strek, M. E. (2016). Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. RESPIRATORY MEDICINE, 121, 117-122. doi:10.1016/j.rmed.2016.11.007

Oldham, J. M., Noth, I., & Martinez, F. J. (2016). Pharmacogenetics and interstitial lung disease. CURRENT OPINION IN PULMONARY MEDICINE, 22(5), 456-465. doi:10.1097/MCP.0000000000000289

Noth, I. (2016). When Is It More Than Just a Spicy Meal?. JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 26(7), 499-500. doi:10.1089/lap.2016.29007.in

Oldham, J. M., Adegunsoye, A., Valenzi, E., Lee, C., Witt, L., Chen, L., . . . Strek, M. E. (2016). Characterisation of patients with interstitial pneumonia with autoimmune features. EUROPEAN RESPIRATORY JOURNAL, 47(6), 1767-1775. doi:10.1183/13993003.01565-2015

Oldham, J. M., Strek, M. E., & Noth, I. (2016). Idiopathic Pulmonary Fibrosis and Hypothyroidism Cannot Forget Subclinical Disease and Difficult-to-Eliminate Corticosteroids Response. CHEST, 149(2), 600-601. doi:10.1016/j.chest.2015.11.014

Maher, T., Noth, I., Allinger, A., Kaul, M., Conoscenti, C. S., & Oelberg, D. (2016). SAFETY AND TOLERABILITY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): ONE-YEAR DATA FROM POST-MARKETING SURVEILLANCE IN THE UNITED STATES. THORAX, 71, A175. doi:10.1136/thoraxjnl-2016-209333.311

Adegunsoye, A., Hrusch, C. L., Bonham, C. A., Jaffrey, M. R., Blaine, K. M., Sullivan, M., . . . Sperling, A. I. (2016). Skewed Lung CCR4 to CCR6 CD4⁺ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function. FRONTIERS IN IMMUNOLOGY, 7. doi:10.3389/fimmu.2016.00516

Oldham, J. M., Ma, S. -F., Martinez, F. J., Anstrom, K. J., Raghu, G., Schwartz, D. A., . . . Noth, I. (2015). TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 192(12), 1475-1482. doi:10.1164/rccm.201505-1010OC

Huang, Y., Ma, S. -F., Vij, R., Oldham, J. M., Herazo-Maya, J., Broderick, S. M., . . . Noth, I. (2015). A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis. BMC PULMONARY MEDICINE, 15. doi:10.1186/s12890-015-0142-8

Oldham, J. M., Kumar, D., Lee, C., Patel, S. B., Takahashi-Manns, S., Demchuk, C., . . . Noth, I. (2015). Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. CHEST, 148(3), 692-700. doi:10.1378/chest.14-2714

Huang, L. S., Berdyshev, E. V., Tran, J. T., Xie, L., Chen, J., Ebenezer, D. L., . . . Natarajan, V. (2015). Sphingosine-1-phosphate lyase is an endogenous suppressor of pulmonary fibrosis: role of S1P signalling and autophagy. THORAX, 70(12), 1138-1148. doi:10.1136/thoraxjnl-2014-206684

Fischer, A., Antoniou, K. M., Brown, K. K., Cadranel, J., Corte, T. J., du Bois, R. M., . . . Cottin, V. (2015). An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. EUROPEAN RESPIRATORY JOURNAL, 46(4), 976-987. doi:10.1183/13993003.00150-2015

Vij, R., Denton, C. P., & Noth, I. (2015). Molecular Phenotyping A Guide to Improving Detection of Interstitial Lung Disease in Patients with Rheumatoid Arthritis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 191(12), 1349-1350. doi:10.1164/rccm.201504-0751ED

Stanley, S. E., Noth, I., & Armanios, M. (2015). What the Genetics "RTEL"ing Us about Telomeres and Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 191(6), 608-610. doi:10.1164/rccm.201501-0119ED

Wilkes, D. S., Chew, T., Flaherty, K. R., Frye, S., Gibson, K. F., Kaminski, N., . . . Rothhaar, K. (2015). Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis. EUROPEAN RESPIRATORY JOURNAL, 45(5), 1393-1402. doi:10.1183/09031936.00105314

Stuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., . . . Garcia, C. K. (2014). Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. LANCET RESPIRATORY MEDICINE, 2(7), 557-565. doi:10.1016/S2213-2600(14)70124-9

Huang, L. S., Mathew, B., Li, H., Zhao, Y., Ma, S. -F., Noth, I., . . . Natarajan, V. (2014). The Mitochondrial Cardiolipin Remodeling Enzyme Lysocardiolipin Acyltransferase Is a Novel Target in Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 189(11), 1402-1415. doi:10.1164/rccm.201310-1917OC

Han, M. K., Zhou, Y., Murray, S., Tayob, N., Noth, I., Lama, V. N., . . . Martinez, F. J. (2014). Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. LANCET RESPIRATORY MEDICINE, 2(7), 548-556. doi:10.1016/S2213-2600(14)70069-4

Sweiss, N. J., Noth, I., Mirsaeidi, M., Zhang, W., Naureckas, E. T., Hogarth, D. K., . . . Baughman, R. P. (2014). EFFICACY RESULTS OF A 52-WEEK TRIAL OF ADALIMUMAB IN THE TREATMENT OF REFRACTORY SARCOIDOSIS. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 31(1), 46-54. Retrieved from https://www.webofscience.com/

Oldham, J. M., & Noth, I. (2014). Idiopathic pulmonary fibrosis: Early detection and referral. RESPIRATORY MEDICINE, 108(6), 819-829. doi:10.1016/j.rmed.2014.03.008

Noth, I., & Olman, M. A. (2014). Rationale for Anticoagulant Therapy of Pulmonary Fibrosis Reply. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 189(3), 363. doi:10.1164/rccm.201307-1328LE

Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., . . . Eu, J. P. (2014). Future Directions in Idiopathic Pulmonary Fibrosis Research. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 189(2), 214-222. doi:10.1164/rccm.201306-1141WS

Wei, R., Li, C., Zhang, M., Jones-Hall, Y. L., Myers, J. L., Noth, I., & Liu, W. (2014). Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. TRANSLATIONAL RESEARCH, 163(5), 494-502. doi:10.1016/j.trsl.2013.12.006

Noth, I., & Kaminski, N. (2013). Idiopathic Pulmonary Fibrosis: Time to Get Personal?. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 188(12), 1392-1394. doi:10.1164/rccm.201311-1956ED

Takahashi, S. M., & Noth, I. (2013). GERD and idiopathic pulmonary fibrosis: cause or effect. Current Respiratory Care Reports, 2(4), 260-267. doi:10.1007/s13665-013-0066-9

Herazo-Maya, J. D., Noth, I., Duncan, S. R., Kim, S., Ma, S. -F., Tseng, G. C., . . . Kaminski, N. (2013). Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis. SCIENCE TRANSLATIONAL MEDICINE, 5(205). doi:10.1126/scitranslmed.3005964

Allaix, M. E., Fisichella, P. M., Noth, I., Herbella, F. A., Segura, B. B., & Patti, M. G. (2014). Idiopathic Pulmonary Fibrosis and Gastroesophageal Reflux. Implications for Treatment. JOURNAL OF GASTROINTESTINAL SURGERY, 18(1), 100-104. doi:10.1007/s11605-013-2333-z

Sun, X., Ma, S. -F., Wade, M. S., Acosta-Herrera, M., Villar, J., Pino-Yanes, M., . . . Garcia, J. G. N. (2013). Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 305(7), L467-L477. doi:10.1152/ajplung.00010.2013

Lee, J. S., Collard, H. R., Anstrom, K. J., Martinez, F. J., Noth, I., Roberts, R. S., . . . Raghu, G. (2013). Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. LANCET RESPIRATORY MEDICINE, 1(5), 369-376. doi:10.1016/S2213-2600(13)70105-X

Peljto, A. L., Zhang, Y., Fingerlin, T. E., Ma, S. -F., Garcia, J. G. N., Richards, T. J., . . . Schwartz, D. A. (2013). Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 309(21), 2232-2239. doi:10.1001/jama.2013.5827

Noth, I., & Olman, M. (2013). A Placebo-controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis: A Hidden Subgroup? Reply. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 187(9), 1030. doi:10.1164/rccm.201211-2060LE

Allaix, M. E., Fisichella, P. M., Noth, I., Mendez, B. M., & Patti, M. G. (2013). The Pulmonary Side of Reflux Disease: from Heartburn to Lung Fibrosis. JOURNAL OF GASTROINTESTINAL SURGERY, 17(8), 1526-1535. doi:10.1007/s11605-013-2208-3

Noth, I., Zhang, Y., Ma, S. -F., Flores, C., Barber, M., Huang, Y., . . . Garcia, J. G. N. (2013). Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. LANCET RESPIRATORY MEDICINE, 1(4), 309-317. doi:10.1016/S2213-2600(13)70045-6

Noth, I., & Olman, M. (2013). Warfarin in Idiopathic Pulmonary Fibrosis: Friend or Foe, Is It a Matter of Genes and Heparin? Reply. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 187(2), 214. doi:10.1164/ajrccm.187.2.214

Huang, L. S., Berdyshev, E., Mathew, B., Fu, P., Gorshkova, I. A., He, D., . . . Natarajan, V. (2013). Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis. FASEB JOURNAL, 27(4), 1749-1760. doi:10.1096/fj.12-219634

Cipriani, N. A., Strek, M., Noth, I., Gordon, I. O., Charbeneau, J., Krishnan, J. A., . . . Husain, A. N. (2012). Pathologic Quantification of Connective Tissue Disease-Associated Versus Idiopathic Usual Interstitial Pneumonia. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 136(10), 1253-1258. doi:10.5858/arpa.2012-0102-OA

Swigris, J. J., Han, M., Vij, R., Noth, I., Eisenstein, E. L., Anstrom, K. J., . . . Fairclough, D. (2012). The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. RESPIRATORY MEDICINE, 106(10), 1447-1455. doi:10.1016/j.rmed.2012.06.018

Noth, I., Anstrom, K. J., Calvert, S. B., de Andrade, J., Flaherty, K. R., Glazer, C., . . . Olman, M. A. (2012). A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 186(1), 88-95. doi:10.1164/rccm.201202-0314OC

Vij, R., & Noth, I. (2012). Peripheral blood biomarkers in idiopathic pulmonary fibrosis. TRANSLATIONAL RESEARCH, 159(4), 218-227. doi:10.1016/j.trsl.2012.01.012

Noth, I., Vij, R., & Strek, M. E. (2012). Interstitial Lung Disease and Antinuclear Antibody Consider Nonspecific Interstitial Pneumonia Histology and Newer Antibodies Response. CHEST, 141(5), 1361. doi:10.1378/chest.12-0026

Noth, I., & Olman, M. (2012). Is Warfarin the Right Anticoagulant in Idiopathic Pulmonary Fibrosis? Reply. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 186(7), 693-694. doi:10.1164/ajrccm.186.7.693a

Zhou, T., Zhang, W., Sweiss, N. J., Chen, E. S., Moller, D. R., Knox, K. S., . . . Garcia, J. G. N. (2012). Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis. PLOS ONE, 7(9). doi:10.1371/journal.pone.0044818

Noth, I., Gibson, K. F., & Drake, W. P. (2011). Where Next for Gene Expression Profiling? So Much Promise. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 184(10), 1102-1103. doi:10.1164/rccm.201109-1612ED

Noth, I., Zangan, S. M., Soares, R. V., Forsythe, A., Demchuk, C., Takahashi, S. M., . . . MacMahon, H. (2012). Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. EUROPEAN RESPIRATORY JOURNAL, 39(2), 344-351. doi:10.1183/09031936.00099910

Vij, R., Noth, I., & Strek, M. E. (2011). Autoimmune-Featured Interstitial Lung Disease A Distinct Entity. CHEST, 140(5), 1292-1299. doi:10.1378/chest.10-2662

Zhang, Y., Noth, I., Garcia, J. G. N., & Kaminski, N. (2011). A Variant in the Promoter of MUC5B and Idiopathic Pulmonary Fibrosis. NEW ENGLAND JOURNAL OF MEDICINE, 364(16), 1576-1577. doi:10.1056/NEJMc1013504

Xue, J., Gochuico, B. R., Alawad, A. S., Feghali-Bostwick, C. A., Noth, I., Nathan, S. D., . . . Duncan, S. R. (2011). The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis. PLOS ONE, 6(2). doi:10.1371/journal.pone.0014715

Soares, R. V., Forsythe, A., Hogarth, K., Sweiss, N. J., Noth, I., & Patti, M. G. (2011). Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment.. Arquivos de gastroenterologia, 48(2), 91-97. doi:10.1590/s0004-28032011000200002

White, S. R., Loisel, D. A., McConville, J. F., Stern, R., Tu, Y., Marroquin, B. A., . . . Ober, C. (2010). Levels of soluble human leukocyte antigen-G are increased in asthmatic airways. EUROPEAN RESPIRATORY JOURNAL, 35(4), 925-927. doi:10.1183/09031936.00164809

Anstrom, K. J., Kaner, R. J., Loyd, J. E., Roman, J., Brown, K. K., King, T. E. J., . . . Reynolds, H. Y. (2010). The IPFnet Strategy Creating a Comprehensive Approach in the Treatment of Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 181(6), 527-528. doi:10.1164/rccm.200903-0483ED